Open AccessIs spironolactone effective in preventing atypical pneumonia caused by COVID-19 in patients with hypertension?
Author(s) -
V. Yе. Sabadash,
O. О. Alifer,
E. N. Zakharets
Publication year - 2020
Publication title -
lìki ukraïni
Language(s) - English
Resource type - Journals
ISSN - 1997-9894
DOI - 10.37987/1997-9894.2020.4(240).214421
Subject(s) - spironolactone , medicine , diuretic , covid-19 , pneumonia , pharmacology , cardiology , intensive care medicine , heart failure , virology , disease , outbreak , infectious disease (medical specialty)